Demonstrate the Value of Using Hypnosis in Chimiotherapy- Induced Chronic Neuropathies
NCT ID: NCT03156595
Last Updated: 2021-10-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
108 participants
INTERVENTIONAL
2017-08-04
2021-11-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypnosis, as a non-invasive tool without physical side effects, might be used to relieve them.
the purpose of this trial based on our own experience, is to demonstrate the value of using hypnosis and self-hypnosis in chimiotherapy- induced chronic neuropathies.
The aim will be to sustainably improve the quality of life by expanding self-management of pain and motor function side effect.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nurse interview
Personal interview with nurses to evaluate the relief of neuropathic pains with the reference treatment. (If necessary send to the medical team ) It's a listening time around neuropathic pain which altered the quality of life.
Nurse interview
Personal interview with nurses to evaluate the relief of neuropathic pains with the reference treatment. (If necessary send to the medical team ) It's a listening time around neuropathic pain which altered the quality of life.
Hypnosis session
Hypnosis sessions with nurses or psychologists, with deepening sessions to facilitate self-hypnosis learning.
Hypnosis sessions
Hypnosis sessions with a nurse or psychologist, with deepening sessions to facilitate self-hypnosis learning.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nurse interview
Personal interview with nurses to evaluate the relief of neuropathic pains with the reference treatment. (If necessary send to the medical team ) It's a listening time around neuropathic pain which altered the quality of life.
Hypnosis sessions
Hypnosis sessions with a nurse or psychologist, with deepening sessions to facilitate self-hypnosis learning.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Chemiotherapy- induced chronic neuropathies for at least 2 months with a DN4 score \>4
* Failure of classic treatment used to relief neuropathic
* Having stopped chemotherapy treatment and being in complete or partial response or in tumoral stability
* Without any planed chemiotherapy during the study
* Having signed a written informed consent.
* French efficient understanding
* With health insurance coverage
* availability during all the study
* With efficient contraception for women of childbearing age
Exclusion Criteria
* Suffering from neuropathy before having chemotherapy
* Other disease that may cause neuropathy
* deafness
* Any medicine that could cause neuropathy
* Neurological or psychiatrical disease past or present
* Mental retardation
* Allergy to EMG's electrodes
* Unable to consent, under tutelage or curatorship or judiciary safeguard
* Pregnant or nursing woman
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Strasbourg, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Caroline MAURER, Nurse
Role: STUDY_CHAIR
Strasbourg's University Hospitals
Raoul HERBRECHT, MD
Role: PRINCIPAL_INVESTIGATOR
Strasbourg's University Hospitals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Strasbourg Hospital
Strabsourg, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PHRIP 2015 - HUS n°6395
Identifier Type: -
Identifier Source: org_study_id